FOXO Technologies Inc. announced plans for a new subscription-based, direct-to-consumer product offering that will provide personalized health and wellness recommendations, by combining: (i) FOXO's machine learning models to analyze epigenetic biomarkers; (ii) the Company's expertise and algorithms correlating epigenetic analysis with health outcomes; and (iii) published, peer-reviewed, clinical data and other verified, third-party health resources. In connection with the new offering, the Company also announced it has formed a collaboration with KR8.ai Inc. ("KR8") and secured an exclusive license to KR8's AI-based software to support the development and commercial launch of the new health and wellness offering.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4753 USD | +39.51% | +35.03% | +48.67% |
Apr. 28 | FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC | CI |
Apr. 24 | Sector Update: Tech Stocks Higher Premarket Wednesday | MT |
1st Jan change | Capi. | |
---|---|---|
+48.67% | 4.8M | |
-19.53% | 177B | |
-3.23% | 159B | |
+2.05% | 153B | |
+5.13% | 100B | |
+9.84% | 81.1B | |
+22.85% | 75.87B | |
-8.81% | 69.81B | |
-31.57% | 45.59B | |
-9.69% | 42.96B |
- Stock Market
- Equities
- FOXO Stock
- News FOXO Technologies Inc.
- FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai